CN108939165A - Peripheral nerve scaffold and preparation method thereof - Google Patents
Peripheral nerve scaffold and preparation method thereof Download PDFInfo
- Publication number
- CN108939165A CN108939165A CN201810660207.XA CN201810660207A CN108939165A CN 108939165 A CN108939165 A CN 108939165A CN 201810660207 A CN201810660207 A CN 201810660207A CN 108939165 A CN108939165 A CN 108939165A
- Authority
- CN
- China
- Prior art keywords
- peripheral nerve
- gauze
- ink
- filler
- dimensional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000578 peripheral nerve Anatomy 0.000 title claims abstract description 77
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 229910000861 Mg alloy Inorganic materials 0.000 claims abstract description 29
- 239000000945 filler Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 14
- 230000028600 axonogenesis Effects 0.000 claims abstract description 8
- 238000010146 3D printing Methods 0.000 claims description 27
- 239000000017 hydrogel Substances 0.000 claims description 18
- 210000001519 tissue Anatomy 0.000 claims description 14
- 102100023995 Beta-nerve growth factor Human genes 0.000 claims description 11
- 238000002788 crimping Methods 0.000 claims description 10
- 239000000499 gel Substances 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- 102000057297 Pepsin A Human genes 0.000 claims description 8
- 108090000284 Pepsin A Proteins 0.000 claims description 8
- 229940111202 pepsin Drugs 0.000 claims description 8
- 101710129634 Beta-nerve growth factor Proteins 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 239000005445 natural material Substances 0.000 claims description 6
- 210000004027 cell Anatomy 0.000 claims description 5
- 230000029087 digestion Effects 0.000 claims description 5
- 238000007639 printing Methods 0.000 claims description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 4
- 210000001691 amnion Anatomy 0.000 claims description 4
- 210000002826 placenta Anatomy 0.000 claims description 4
- 210000000278 spinal cord Anatomy 0.000 claims description 4
- 210000004876 tela submucosa Anatomy 0.000 claims description 4
- 210000003954 umbilical cord Anatomy 0.000 claims description 4
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- -1 norborneol Alkene modified hyaluronic acid Chemical class 0.000 claims description 3
- 230000010412 perfusion Effects 0.000 claims description 3
- 230000008595 infiltration Effects 0.000 claims description 2
- 238000001764 infiltration Methods 0.000 claims description 2
- 210000000813 small intestine Anatomy 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 12
- 230000008827 biological function Effects 0.000 abstract description 7
- 239000011664 nicotinic acid Substances 0.000 abstract description 5
- 230000035699 permeability Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000004071 biological effect Effects 0.000 abstract description 2
- 230000008571 general function Effects 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 239000000976 ink Substances 0.000 description 30
- 238000005516 engineering process Methods 0.000 description 9
- 210000005036 nerve Anatomy 0.000 description 8
- 239000000203 mixture Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 230000009977 dual effect Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- 210000003050 axon Anatomy 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 241000282887 Suidae Species 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000003376 axonal effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010017 direct printing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3675—Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Manufacturing & Machinery (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
本发明公开了一种周围神经支架,外套管和设于外套管内的填充物,填充物是纱网卷曲而成的三维骨架,纱网采用生物墨水制成;本发明还公开了周围神经支架的制备方法。采用本发明的方法制备的周围神经支架具有天然周围神经的结构及组成的仿生要素;在镁合金外套管保证生物相容基础上,提供支架充分结构稳定性,填充物在制造过程中可以降低对墨水成型强度要求,扩大了填充物的选材范围,以便墨水可以选择更多的生物功能;本发明采用3D打印二维纱网,然后叠加或卷曲作为填充物骨架,可以准确调控骨架的结构及通透性;本发明通过对骨架灌注或浸润特定功能组分,为填充物提供相应的生物学特性,比如促进轴突的生长、促进血管化。
The invention discloses a peripheral nerve stent, an outer casing and a filler arranged in the outer casing, the filler is a three-dimensional skeleton formed by curling gauze, and the gauze is made of bio-ink; the invention also discloses the peripheral nerve stent Preparation. The peripheral nerve stent prepared by the method of the present invention has the structure and bionic elements of the natural peripheral nerve; on the basis of ensuring the biocompatibility of the magnesium alloy outer sleeve, the sufficient structural stability of the stent is provided, and the filler can reduce the impact on the stent during the manufacturing process. Ink molding strength requirements expand the range of material selection for fillers, so that the ink can select more biological functions; the present invention uses 3D printed two-dimensional gauze, and then superimposes or curls it as the skeleton of the filler, which can accurately control the structure of the skeleton and its general function. Permeability: The present invention provides fillers with corresponding biological properties, such as promoting axon growth and vascularization, by perfusing or infiltrating specific functional components into the skeleton.
Description
技术领域technical field
本发明涉及组织工程和仿生结构技术领域,尤其是一种周围神经支架及其制备方法。The invention relates to the technical field of tissue engineering and bionic structures, in particular to a peripheral nerve support and a preparation method thereof.
背景技术Background technique
周围神经的解剖结构复杂,分为神经外膜区、神经束区和神经束间区等,各个区域内还分布有微血管、结缔组织等功能结构。此外,不同区域的组成成分及空间分布也非常复杂。目前文献报道的神经修复材料(或导管)主要采用单一均质材料制备(如合成材料、天然材料、去细胞基质材料),依据神经再生的原理,导管的结构与组成也进行了仿生设计(如神经生长因子梯度分布等),但是这类支架在组成及结构依然较为单一,无法体现天然神经的复杂组成及结构。The anatomical structure of the peripheral nerve is complex, which is divided into epineurium area, nerve fascicular area and interfascicular area, etc. There are also functional structures such as microvessels and connective tissue distributed in each area. In addition, the composition and spatial distribution of different regions are also very complex. Nerve repair materials (or catheters) currently reported in the literature are mainly prepared from a single homogeneous material (such as synthetic materials, natural materials, and acellular matrix materials). According to the principle of nerve regeneration, the structure and composition of the catheter have also been bionically designed (such as Gradient distribution of nerve growth factor, etc.), but this kind of scaffold is still relatively simple in composition and structure, and cannot reflect the complex composition and structure of natural nerves.
生物3D打印技术相比传统加工技术,对于复杂组织结构的制造及不同组分空间分布具有显著优势。3D打印最为重要的是生物墨水。热塑性的可降解聚醚酯材料,虽然打印工艺成熟,打印后稳定,但其与周围神经的力学性质差异较大,且高温的打印条件难以实现对细胞或活性蛋白的负载。而适于细胞生长的生物墨水材料强度普遍较低、稳定性不佳,难以满足直接打印成型及后期使用中稳定性的需求。目前尚没有较为完善的使用生物相容性良好的水凝胶类墨水材料3D打印周围神经支架的工艺。Compared with traditional processing technologies, bio-3D printing technology has significant advantages in the manufacture of complex tissue structures and the spatial distribution of different components. The most important thing about 3D printing is bio-ink. Although the thermoplastic degradable polyether ester material has a mature printing process and is stable after printing, its mechanical properties are quite different from those of peripheral nerves, and it is difficult to load cells or active proteins under high temperature printing conditions. However, bio-ink materials suitable for cell growth are generally low in strength and poor in stability, and it is difficult to meet the needs of direct printing and stability in later use. At present, there is no relatively complete process for 3D printing peripheral nerve scaffolds using hydrogel ink materials with good biocompatibility.
发明内容Contents of the invention
基于上述问题,本发明的目的在于克服上述现有技术的不足之处而提供一种基于镁合金外结构和3D打印技术的周围神经支架,其兼具生物活性功能和结构稳定性。Based on the above problems, the purpose of the present invention is to overcome the shortcomings of the above-mentioned prior art and provide a peripheral nerve scaffold based on magnesium alloy outer structure and 3D printing technology, which has both bioactive function and structural stability.
为实现上述目的,本发明采取的技术方案为:一种周围神经支架,包括外套管和设于所述外套管内的填充物,所述填充物是纱网卷曲而成的三维骨架,所述纱网采用生物墨水制成。In order to achieve the above object, the technical solution adopted by the present invention is: a peripheral nerve stent, comprising an outer sleeve and a filler arranged in the outer sleeve, the filler is a three-dimensional skeleton formed by crimping gauze, and the gauze The mesh is made with bio-ink.
其中,(二维)纱网的网格结构为矩形,根据需要还可以调整为棱形、正方形、平行四边形等,通过调节纱网网格的大小和形状,可改变伞为骨架的强度、纵向和横向的通透性(提供引导轴突定向生长物理信号);填充物的结构仿制了神经再生区域;三维骨架具有多孔结构,有利于具有一定生物功能的凝胶材料或溶液的浸入,从而引入特定生物功能或微观结构。Among them, the grid structure of the (two-dimensional) gauze is rectangular, and it can also be adjusted to a prismatic, square, parallelogram, etc. as required. By adjusting the size and shape of the gauze grid, the strength, longitudinal and lateral permeability (provide physical signals to guide the directional growth of axons); the structure of the filler imitates the nerve regeneration area; the three-dimensional skeleton has a porous structure, which is conducive to the immersion of gel materials or solutions with certain biological functions, thereby introducing Specific biological function or microstructure.
优选地,所述外套管为镁合金套管。其中,镁合金套管的制备通过五金加工或镁合金丝编织制造,可参考专利CN103598927和CN104107096A,其结构仿制神经外膜。Preferably, the outer sleeve is a magnesium alloy sleeve. Among them, the magnesium alloy casing is manufactured by metal processing or magnesium alloy wire braiding, and patents CN103598927 and CN104107096A can be referred to, and its structure imitates the epineurium.
优选地,所述纱网采用3D打印方法制成。Preferably, the gauze is made by 3D printing.
优选地,所述生物墨水含有丙烯酸双键端基改性PEG制备的水凝胶、天然材料以及组织脱细胞水凝胶中的至少一种。Preferably, the bio-ink contains at least one of hydrogel prepared by acrylic acid double bond terminal modified PEG, natural material and tissue decellularized hydrogel.
优选地,所述天然材料为丙烯酸或降冰片烯改性的透明质酸、明胶或胶原。Preferably, said natural material is acrylic or norbornene modified hyaluronic acid, gelatin or collagen.
优选地,所述组织为周围神经、脊髓、小肠粘膜下层、脐带、胎盘或羊膜。更优选地,组织源自人或猪。Preferably, the tissue is peripheral nerves, spinal cord, small intestinal submucosa, umbilical cord, placenta or amniotic membrane. More preferably, the tissue is of human or porcine origin.
优选地,所述三维骨架上灌注或浸润有可促进轴突生长或血管化的凝胶或溶液。其中,促进血管化的凝胶或溶液优选含有VEGF。Preferably, the three-dimensional framework is perfused or infiltrated with a gel or a solution that can promote axon growth or vascularization. Among them, the gel or solution for promoting vascularization preferably contains VEGF.
优选地,所述三维骨架上灌注或浸润有含有β-NGF的溶液,以促进轴突生长;或者猪来源的周围神经经过脱细胞、粉碎后经胃蛋白酶消化得到的水凝胶。Preferably, the three-dimensional framework is perfused or infiltrated with a solution containing β-NGF to promote axon growth; or a hydrogel obtained by decellularizing and pulverizing peripheral nerves from pigs and digesting them with pepsin.
作为本发明的另一个方面,本发明还提供了一种周围神经支架的制备方法,包括如下步骤:As another aspect of the present invention, the present invention also provides a method for preparing a peripheral nerve scaffold, comprising the steps of:
(1)提供镁合金外套管;(1) Provide magnesium alloy outer casing;
(2)采用具有温度、紫外光双敏感特性的墨水和3D打印方法制备二维纱网,其中,3D打印料筒温度为24~28℃,成型区域温度控制为4~12℃;(2) Two-dimensional gauze is prepared by using ink with dual sensitivity to temperature and ultraviolet light and 3D printing method, wherein the temperature of the 3D printing barrel is 24-28°C, and the temperature of the forming area is controlled at 4-12°C;
(3)保持步骤(2)所得二维纱网在上述低温环境,采用光强为0.1~3mv/cm2的365nm UV辐照8s~2min;然后,通过卷曲或裁剪叠加,制得三维骨架;由此,打印成型的二维纱网结构中聚合物可以化学交联,提高打印出的二维纱网软模型的稳定性;(3) keeping the two-dimensional gauze obtained in step (2) in the above-mentioned low-temperature environment, using 365nm UV radiation with a light intensity of 0.1-3mv/cm2 for 8s-2min; then, by crimping or cutting and superimposing, a three-dimensional skeleton is obtained; Therefore, the polymer in the printed two-dimensional gauze structure can be chemically cross-linked to improve the stability of the printed two-dimensional gauze soft model;
(4)采用浓度为100pg/ml~10μg/ml的神经生长因子β-NGF的溶液或/和质量浓度为0.1~10%的猪来源周围神经经过脱细胞、粉碎后经胃蛋白酶消化得到的水凝胶浸润或者灌注到步骤(3)所得三维骨架,然后装填到所述镁合金外套管中,制得所述周围神经支架。(4) Use a solution of nerve growth factor β-NGF with a concentration of 100pg/ml-10μg/ml or/and a solution of pig-derived peripheral nerves with a mass concentration of 0.1-10% after decellularization, pulverization, and digestion with pepsin. The gel is infiltrated or perfused into the three-dimensional skeleton obtained in step (3), and then filled into the magnesium alloy outer casing to obtain the peripheral nerve scaffold.
其中,墨水含有丙烯酸双键端基改性PEG制备的水凝胶、天然材料以及组织脱细胞水凝胶中的至少一种;天然材料优选为丙烯酸或降冰片烯改性的透明质酸、明胶或胶原;步骤(2)中,可以根据需求设计打印二维纱网模型,初始利用墨水的温度敏感性打印成型;步骤(4)中,经过浸润或者灌注,对支架进行生物学的修饰,以利于神经轴突的延伸生长。Wherein, the ink contains at least one of hydrogel prepared by acrylic acid double bond terminal modified PEG, natural material and tissue decellularized hydrogel; natural material is preferably acrylic acid or norbornene modified hyaluronic acid, gelatin or collagen; in step (2), the two-dimensional gauze model can be designed and printed according to the requirements, and the temperature sensitivity of the ink is initially used for printing; in step (4), the scaffold is biologically modified after infiltration or perfusion to Conducive to the extension and growth of nerve axons.
综上所述,本发明的有益效果为:In summary, the beneficial effects of the present invention are:
(1)本发明的周围神经支架具有天然周围神经的结构及组成的仿生要素;(1) the peripheral nerve support of the present invention has the structure of the natural peripheral nerve and the bionic elements of composition;
(2)镁合金外套管保证生物相容基础上,提供支架充分结构稳定性,填充物在制造过程中可以降低对墨水成型强度要求,扩大了填充物的选材范围,以便墨水可以选择更多的生物功能;(2) On the basis of ensuring biocompatibility, the magnesium alloy outer sleeve provides sufficient structural stability of the stent. During the manufacturing process, the filler can reduce the requirements for the forming strength of the ink, and expand the material selection range of the filler, so that the ink can choose more. biological function;
(3)采用3D打印二维纱网,然后叠加或卷曲作为填充物骨架,可以准确调控骨架的结构及通透性;(3) Using 3D printed two-dimensional gauze, and then superimposing or curling it as the filler skeleton, can accurately control the structure and permeability of the skeleton;
(4)本发明通过对骨架灌注或浸润特定功能组分,为填充物提供相应的生物学特性,比如促进轴突的生长、促进血管化;(4) The present invention provides fillers with corresponding biological characteristics, such as promoting axon growth and vascularization, by perfusing or infiltrating specific functional components into the skeleton;
(5)本发明的结构及制备方法简单、易实现。(5) The structure and preparation method of the present invention are simple and easy to realize.
附图说明Description of drawings
图1为本发明的周围神经支架的制备流程示意图;Fig. 1 is the preparation flow schematic diagram of peripheral nerve support of the present invention;
其中,1、外套管,2、三维骨架,3、纱网,4、3D打印机。Wherein, 1. outer sleeve, 2. three-dimensional skeleton, 3. gauze, 4. 3D printer.
具体实施方式Detailed ways
本申请的发明人利用3D打印技术制造二维纱网结构,其中,结构单元根据需求可进行设计为不同形状,随后,通过卷曲或叠加实现三维骨架的制备;为维持打印的三维骨架结构内环境的稳定,减少疤痕的产生,提高临床应用的可操作性,将3D打印的骨架结构与镁合金外套管装配成具有管芯结构的支架;为提高支架的生物功能,可进一步通过灌注或浸润具有一定生物功能的凝胶材料或溶液。The inventor of the present application uses 3D printing technology to manufacture a two-dimensional gauze structure, in which the structural units can be designed into different shapes according to requirements, and then the preparation of the three-dimensional skeleton is realized by curling or stacking; in order to maintain the internal environment of the printed three-dimensional skeleton structure stability, reduce the generation of scars, and improve the operability of clinical applications. The 3D printed skeleton structure and the magnesium alloy outer sleeve are assembled into a scaffold with a tube core structure; in order to improve the biological function of the scaffold, it can be further perfused or infiltrated with A gel material or solution with certain biological functions.
本申请的3D打印填充物是能促进轴突生长的软的凝胶墨水材料,用此墨水打印出的0-5cm细长的周围神经支架的自支撑和稳定性,均无法达到试验及临床对结构稳定性的要求,所以,与镁合金外套管匹配,将3D打印填充物置于外套管内,装配成具有管芯结构的周围神经支架。The 3D printing filler of this application is a soft gel ink material that can promote the growth of axons. The self-support and stability of the 0-5cm slender peripheral nerve scaffolds printed with this ink cannot meet the test and clinical requirements. The requirements of structural stability, therefore, match with the magnesium alloy outer casing, place the 3D printing filler in the outer casing, and assemble it into a peripheral nerve scaffold with a tube core structure.
本申请利用3D打印技术,通过仿生技术制备了兼具生物功能和结构稳定性的周围神经支架;具体地,本发明的周围神经支架具有以下优点:This application uses 3D printing technology to prepare a peripheral nerve scaffold with both biological functions and structural stability through bionic technology; specifically, the peripheral nerve scaffold of the present invention has the following advantages:
1、结构仿生,外套管是维持支架形状稳定性和便于临床缝合操作,填充物为神经再生提供微环境;1. The structure is bionic, the outer sleeve is to maintain the shape stability of the stent and facilitate the clinical suturing operation, and the filler provides a microenvironment for nerve regeneration;
2、外套管选用镁合金,兼顾生物相容性和结构稳定性;镁合金易于加工,可以精确调节参数,比如镁合金组成、多孔结构的孔直径、致密度等;2. The outer casing is made of magnesium alloy, which takes into account both biocompatibility and structural stability; magnesium alloy is easy to process and can precisely adjust parameters, such as magnesium alloy composition, porous structure pore diameter, density, etc.;
3、选取与周围神经力学性质匹配的生物相容性更好的软材料作为3D打印墨水,传统工艺制备的周围神经导管则必须满足一定力学性质以维持稳定性,因此,其力学性质一般要远高于天然的周围神经。此外,本发明中的复合墨水包括利于成型的改性凝胶和周围神经去细胞组织水凝胶,兼顾了3D可打印性质和特异的生物活性;3. Select soft materials with better biocompatibility that match the mechanical properties of peripheral nerves as 3D printing inks. Peripheral nerve catheters prepared by traditional techniques must meet certain mechanical properties to maintain stability. Therefore, their mechanical properties are generally far superior higher than the natural peripheral nerves. In addition, the composite ink in the present invention includes a modified gel and peripheral nerve decellularized tissue hydrogel that are conducive to shaping, taking into account 3D printable properties and specific biological activities;
4、由于组织工程支架要充分考虑营养的输送,本申请中结构单元的设计可以调节材料的通透性(通过网格),利于物质的输送;此外,三维骨架可以均匀或梯度的负载生物信号分子,实现信号的空间分布,引导轴突定向延伸;4. Since the tissue engineering scaffold should fully consider the transportation of nutrients, the design of the structural unit in this application can adjust the permeability of the material (through the grid), which is conducive to the transportation of substances; in addition, the three-dimensional skeleton can load biological signals uniformly or gradiently Molecules, realize the spatial distribution of signals, and guide the directional extension of axons;
5、可以根据需要调节支架的结构及通透性;5. The structure and permeability of the bracket can be adjusted according to the needs;
6、本发明的三维骨架中还可加入能促进轴突生长活力或提高血管长入速度的生物活性分子,以提高早期细胞的存活增殖,利于长段神经缺损修复。6. The three-dimensional framework of the present invention can also add bioactive molecules that can promote axonal growth activity or increase the speed of blood vessel growth, so as to improve the survival and proliferation of early cells and facilitate the repair of long-segment nerve defects.
为更好的说明本发明的目的、技术方案和优点,下面将结合附图和具体实施例对本发明作进一步说明。如无特别说明,本申请中的技术,例如镁合金套管的制备和3D打印技术,均属于本领域公知技术,本领域普通技术人员结合公知技术和本申请中的相关技术方案,不需要付出创造性的工作,即可实现相应的结构或产品。In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with the accompanying drawings and specific embodiments. Unless otherwise specified, the technologies in this application, such as the preparation of magnesium alloy sleeves and 3D printing technology, all belong to the well-known technologies in this field. Creative work can realize the corresponding structure or product.
实施例1Example 1
如图1所示,本发明的周围神经支架的一种实施例,包括外套管1和设于外套管1内的填充物,填充物是纱网3卷曲而成的三维骨架2,纱网3采用生物墨水制成,外套管1为镁合金套管,纱网3采用3D打印方法制成。As shown in Figure 1, an embodiment of the peripheral nerve stent of the present invention comprises an outer casing 1 and a filler disposed in the outer casing 1, the filler is a three-dimensional skeleton 2 formed by crimping a gauze 3, and the gauze 3 Made of bio-ink, the outer sleeve 1 is a magnesium alloy sleeve, and the gauze 3 is made by 3D printing.
其中,生物墨水为丙烯酸双键端基改性PEG制备的水凝胶;三维骨架上灌注或浸润有可促进轴突生长的溶液,其中含有β-NGF。Wherein, the bio-ink is a hydrogel prepared by modifying PEG with double bond end groups of acrylic acid; the three-dimensional skeleton is perfused or infiltrated with a solution that can promote axon growth, which contains β-NGF.
上述周围神经支架的制备方法,包括如下步骤:The preparation method of above-mentioned peripheral nerve stent, comprises the steps:
(1)提供镁合金外套管;(1) Provide magnesium alloy outer casing;
(2)采用具有温度、紫外光双敏感特性的墨水(即生物墨水)和3D打印方法制备二维纱网,其中,3D打印料筒温度为24℃,成型区域温度控制为6℃;(2) Two-dimensional gauze was prepared by using an ink with dual sensitivity to temperature and ultraviolet light (bio-ink) and a 3D printing method, wherein the temperature of the 3D printing barrel was 24°C, and the temperature of the forming area was controlled at 6°C;
(3)保持步骤(2)所得二维纱网在上述低温环境,采用光强为3mv/cm2的365nm UV辐照8s;然后,通过卷曲或裁剪叠加,制得三维骨架;(3) keeping the two-dimensional gauze obtained in step ( 2 ) in the above-mentioned low-temperature environment, using 365nm UV radiation with a light intensity of 3mv/cm for 8s; then, by curling or cutting and superimposing, a three-dimensional skeleton is obtained;
(4)采用浓度为100pg/ml的神经生长因子β-NGF的溶液浸润或者灌注到步骤(3)所得三维骨架,然后装填到所述镁合金外套管中,制得所述周围神经支架。(4) Infiltrate or perfuse the three-dimensional framework obtained in step (3) with a solution of nerve growth factor β-NGF with a concentration of 100 pg/ml, and then fill it into the magnesium alloy outer sleeve to prepare the peripheral nerve scaffold.
之后,将周围神经支架冷冻干燥,通过扫描电子显微镜(SEM)观察周围神经支架宏、微观结构;周围神经支架置于37℃的PBS中持续观察其形貌稳定性,结果显示,本实施例的周围神经支架在PBS中可以稳定存在6天以上。Afterwards, the peripheral nerve scaffold was freeze-dried, and the macroscopic and microstructure of the peripheral nerve scaffold was observed by scanning electron microscopy (SEM); the peripheral nerve scaffold was placed in PBS at 37°C to continuously observe its shape stability, and the results showed that the Peripheral nerve scaffolds can exist stably in PBS for more than 6 days.
实施例2Example 2
本发明的周围神经支架的一种实施例,包括外套管1和设于外套管1内的填充物,填充物是纱网3卷曲而成的三维骨架2,纱网3采用生物墨水制成,外套管1为镁合金套管,纱网采用3D打印方法制成。An embodiment of the peripheral nerve stent of the present invention includes an outer tube 1 and a filler disposed in the outer tube 1, the filler is a three-dimensional skeleton 2 formed by crimping a gauze 3, the gauze 3 is made of bio-ink, The outer sleeve 1 is a magnesium alloy sleeve, and the gauze is made by 3D printing.
其中,生物墨水为丙烯酸或降冰片烯改性的透明质酸;三维骨架上灌注或浸润有猪来源的周围神经经过脱细胞、粉碎后经胃蛋白酶消化得到的水凝胶。Among them, the bio-ink is hyaluronic acid modified by acrylic acid or norbornene; the three-dimensional framework is perfused or infiltrated with a hydrogel obtained by decellularizing and pulverizing peripheral nerves from pigs and digesting them with pepsin.
上述周围神经支架的制备方法,包括如下步骤:The preparation method of above-mentioned peripheral nerve stent, comprises the steps:
(1)提供镁合金外套管;(1) Provide magnesium alloy outer casing;
(2)采用具有温度、紫外光双敏感特性的墨水(即生物墨水)和3D打印方法制备二维纱网,其中,3D打印料筒温度为25℃,成型区域温度控制为4℃;(2) Two-dimensional gauze was prepared by using ink with dual sensitivity to temperature and ultraviolet light (bio-ink) and 3D printing method, wherein the temperature of the 3D printing barrel was 25°C, and the temperature of the forming area was controlled at 4°C;
(3)保持步骤(2)所得二维纱网在上述低温环境,采用光强为1.5mv/cm2的365nmUV辐照25s;然后,通过卷曲或裁剪叠加,制得三维骨架;(3) keeping the two-dimensional gauze obtained in step ( 2 ) in the above-mentioned low-temperature environment, using 365nmUV irradiation with a light intensity of 1.5mv/cm for 25s; then, by crimping or cutting and superimposing, a three-dimensional skeleton is obtained;
(4)采用质量浓度为0.1~10%的猪来源周围神经经过脱细胞、粉碎后经胃蛋白酶消化得到的水凝胶浸润或者灌注到步骤(3)所得三维骨架,然后装填到所述镁合金外套管中,制得所述周围神经支架。(4) Infiltrate or perfuse the hydrogel obtained by pepsin digestion with the pig-derived peripheral nerve with a mass concentration of 0.1-10% after decellularization and crushing into the three-dimensional skeleton obtained in step (3), and then fill it into the magnesium alloy In the outer cannula, the peripheral nerve scaffold is prepared.
之后,将周围神经支架冷冻干燥,通过扫描电子显微镜(SEM)观察周围神经支架宏、微观结构;周围神经支架置于37℃的PBS中持续观察其形貌稳定性,结果显示,本实施例的周围神经支架在PBS中可以稳定存在7天以上。Afterwards, the peripheral nerve scaffold was freeze-dried, and the macroscopic and microstructure of the peripheral nerve scaffold was observed by scanning electron microscopy (SEM); the peripheral nerve scaffold was placed in PBS at 37°C to continuously observe its shape stability, and the results showed that the Peripheral nerve scaffolds can exist stably in PBS for more than 7 days.
实施例3Example 3
本发明的周围神经支架的一种实施例,包括外套管1和设于外套管1内的填充物,填充物是纱网卷曲而成的三维骨架2,纱网3采用生物墨水制成,外套管1为镁合金套管,纱网采用3D打印方法制成。An embodiment of the peripheral nerve stent of the present invention includes an outer sleeve 1 and a filler disposed in the outer sleeve 1, the filler is a three-dimensional skeleton 2 formed by crimping gauze, the gauze 3 is made of bio-ink, the outer sleeve Tube 1 is a magnesium alloy casing, and the gauze is made by 3D printing.
其中,生物墨水为组织脱细胞水凝胶;组织为猪来源的周围神经、脊髓、小肠粘膜下层、脐带、胎盘或羊膜;三维骨架上灌注或浸润有可促进轴突生长的含有β-NGF的溶液。Among them, the bio-ink is tissue decellularized hydrogel; the tissue is pig-derived peripheral nerve, spinal cord, small intestinal submucosa, umbilical cord, placenta or amniotic membrane; the three-dimensional skeleton is perfused or infiltrated with β-NGF containing β-NGF that can promote axon growth. solution.
上述周围神经支架的制备方法,包括如下步骤:The preparation method of above-mentioned peripheral nerve stent, comprises the steps:
(1)提供镁合金外套管;(1) Provide magnesium alloy outer casing;
(2)采用具有温度、紫外光双敏感特性的墨水(即生物墨水)和3D打印方法制备二维纱网,其中,3D打印料筒温度为27℃,成型区域温度控制为12℃;(2) Two-dimensional gauze was prepared by using an ink with dual sensitivity to temperature and ultraviolet light (bio-ink) and a 3D printing method, wherein the temperature of the 3D printing barrel was 27°C, and the temperature of the forming area was controlled at 12°C;
(3)保持步骤(2)所得二维纱网在上述低温环境,采用光强为0.7mv/cm2的365nmUV辐照1min;然后,通过卷曲或裁剪叠加,制得三维骨架;(3) keeping the two-dimensional gauze obtained in step ( 2 ) in the above-mentioned low-temperature environment, and using 365nmUV irradiation with a light intensity of 0.7mv/cm for 1min; then, by crimping or cutting and superimposing, a three-dimensional skeleton is obtained;
(4)采用浓度为1μg/ml的神经生长因子β-NGF的溶液浸润或者灌注到步骤(3)所得三维骨架,然后装填到所述镁合金外套管中,制得所述周围神经支架。(4) Infiltrate or perfuse the three-dimensional framework obtained in step (3) with a solution of nerve growth factor β-NGF with a concentration of 1 μg/ml, and then fill it into the magnesium alloy outer sleeve to prepare the peripheral nerve scaffold.
之后,将周围神经支架冷冻干燥,通过扫描电子显微镜(SEM)观察周围神经支架宏、微观结构;周围神经支架置于37℃的PBS中持续观察其形貌稳定性,结果显示,本实施例的周围神经支架在PBS中可以稳定存在12天以上。Afterwards, the peripheral nerve scaffold was freeze-dried, and the macroscopic and microstructure of the peripheral nerve scaffold was observed by scanning electron microscopy (SEM); the peripheral nerve scaffold was placed in PBS at 37°C to continuously observe its shape stability, and the results showed that the Peripheral nerve scaffolds can exist stably in PBS for more than 12 days.
实施例4Example 4
本发明的周围神经支架的一种实施例,包括外套管1和设于外套管1内的填充物,填充物是纱网3卷曲而成的三维骨架2,纱网3采用生物墨水制成,外套管1为镁合金套管,纱网3采用3D打印方法制成。An embodiment of the peripheral nerve stent of the present invention includes an outer tube 1 and a filler disposed in the outer tube 1, the filler is a three-dimensional skeleton 2 formed by crimping a gauze 3, the gauze 3 is made of bio-ink, The outer sleeve 1 is a magnesium alloy sleeve, and the gauze 3 is made by 3D printing.
其中,生物墨水含有丙烯酸双键端基改性PEG制备的水凝胶以及组织脱细胞水凝胶;组织为猪来源的周围神经、脊髓、小肠粘膜下层、脐带、胎盘或羊膜;三维骨架上灌注或浸润有可促进轴突生长的含有β-NGF的溶液,以及猪来源的周围神经经过脱细胞、粉碎后经胃蛋白酶消化得到的水凝胶。Among them, the bio-ink contains hydrogels prepared by acrylic acid double bond terminal modified PEG and tissue decellularized hydrogels; the tissues are pig-derived peripheral nerves, spinal cord, small intestinal submucosa, umbilical cord, placenta or amniotic membrane; perfusion on the three-dimensional skeleton Or infiltrated with a solution containing β-NGF that can promote axon growth, and a hydrogel obtained by decellularizing and pulverizing peripheral nerves from pigs and digesting them with pepsin.
上述周围神经支架的制备方法,包括如下步骤:The preparation method of above-mentioned peripheral nerve stent, comprises the steps:
(1)提供镁合金外套管;(1) Provide magnesium alloy outer casing;
(2)采用具有温度、紫外光双敏感特性的墨水(即生物墨水)和3D打印方法制备二维纱网,其中,3D打印料筒温度为28℃,成型区域温度控制为9℃;(2) Two-dimensional gauze was prepared by using ink with dual sensitivity to temperature and ultraviolet light (bio-ink) and 3D printing method, wherein the temperature of the 3D printing barrel was 28°C, and the temperature of the forming area was controlled at 9°C;
(3)保持步骤(2)所得二维纱网在上述低温环境,采用光强为0.1mv/cm2的365nmUV辐照2min;然后,通过卷曲或裁剪叠加,制得三维骨架;(3) keeping the two-dimensional gauze obtained in step (2) in the above-mentioned low-temperature environment, using 365nmUV irradiation with a light intensity of 0.1mv/cm for 2min ; then, by crimping or cutting and superimposing, a three-dimensional skeleton is obtained;
(4)采用浓度为10μg/ml的神经生长因子β-NGF的溶液以及质量浓度为0.1~10%的猪来源周围神经经过脱细胞、粉碎后经胃蛋白酶消化得到的水凝胶浸润或者灌注到步骤(3)所得三维骨架,然后装填到所述镁合金外套管中,制得所述周围神经支架。(4) Use a solution of nerve growth factor β-NGF with a concentration of 10 μg/ml and a pig-derived peripheral nerve with a mass concentration of 0.1 to 10% to infiltrate or infuse the hydrogel obtained by decellularization, pulverization, and digestion with pepsin. The three-dimensional framework obtained in step (3) is then filled into the magnesium alloy outer casing to obtain the peripheral nerve support.
之后,将周围神经支架冷冻干燥,通过扫描电子显微镜(SEM)观察周围神经支架宏、微观结构;周围神经支架置于37℃的PBS中持续观察其形貌稳定性,结果显示,本实施例的周围神经支架在PBS中可以稳定存在8天以上。Afterwards, the peripheral nerve scaffold was freeze-dried, and the macroscopic and microstructure of the peripheral nerve scaffold was observed by scanning electron microscopy (SEM); the peripheral nerve scaffold was placed in PBS at 37°C to continuously observe its shape stability, and the results showed that the Peripheral nerve scaffolds can exist stably in PBS for more than 8 days.
最后所应当说明的是,以上实施例仅用以说明本发明的技术方案而非对本发明保护范围的限制,尽管参照较佳实施例对本发明作了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的实质和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than limit the protection scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that The technical solution of the present invention can be modified or equivalently replaced without departing from the spirit and scope of the technical solution of the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810660207.XA CN108939165A (en) | 2018-06-22 | 2018-06-22 | Peripheral nerve scaffold and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810660207.XA CN108939165A (en) | 2018-06-22 | 2018-06-22 | Peripheral nerve scaffold and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108939165A true CN108939165A (en) | 2018-12-07 |
Family
ID=64486433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810660207.XA Pending CN108939165A (en) | 2018-06-22 | 2018-06-22 | Peripheral nerve scaffold and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108939165A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110772667A (en) * | 2019-11-15 | 2020-02-11 | 中山大学附属第一医院 | Amnion material and preparation method thereof |
| CN111281599A (en) * | 2020-03-19 | 2020-06-16 | 中国海洋大学 | A kind of reinforced artificial nerve conduit and its preparation method and application |
| CN111297513A (en) * | 2020-03-19 | 2020-06-19 | 中国海洋大学 | A kind of artificial nerve conduit loaded with trophic factor and its preparation method and application |
| CN111686306A (en) * | 2020-07-08 | 2020-09-22 | 四川大学 | 3D printing biological ink based on acellular costal cartilage matrix and preparation method and application thereof |
| CN113171494A (en) * | 2021-04-20 | 2021-07-27 | 武汉理工大学 | Method for preparing nerve-induced repair catheter by using extracellular matrix material |
| CN117085182A (en) * | 2023-08-28 | 2023-11-21 | 山东第一医科大学附属眼科研究所(山东省眼科研究所、山东第一医科大学附属青岛眼科医院) | Preparation method and application of biomimetic biological materials |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102085393A (en) * | 2011-01-26 | 2011-06-08 | 东华大学 | Biodegradable nerve conduit with bilayer structure and preparation method thereof |
| CN103598927A (en) * | 2013-10-17 | 2014-02-26 | 上海交通大学 | Degradable magnesium alloy nerve conduit for nerve defect repair and preparation method of nerve conduit |
| CN104645412A (en) * | 2015-01-28 | 2015-05-27 | 南方医科大学 | Preparation method of bionic artificial nerve scaffold established by collagen |
| CN106730010A (en) * | 2017-01-03 | 2017-05-31 | 广州新诚生物科技有限公司 | Acellular nerve hydrogel is used to prepare the purposes of peripheral nerve injury remediation composition |
| CN106913393A (en) * | 2015-12-28 | 2017-07-04 | 山东国际生物科技园发展有限公司 | A kind of artificial neuron support and preparation method and application |
-
2018
- 2018-06-22 CN CN201810660207.XA patent/CN108939165A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102085393A (en) * | 2011-01-26 | 2011-06-08 | 东华大学 | Biodegradable nerve conduit with bilayer structure and preparation method thereof |
| CN103598927A (en) * | 2013-10-17 | 2014-02-26 | 上海交通大学 | Degradable magnesium alloy nerve conduit for nerve defect repair and preparation method of nerve conduit |
| CN104645412A (en) * | 2015-01-28 | 2015-05-27 | 南方医科大学 | Preparation method of bionic artificial nerve scaffold established by collagen |
| CN106913393A (en) * | 2015-12-28 | 2017-07-04 | 山东国际生物科技园发展有限公司 | A kind of artificial neuron support and preparation method and application |
| CN106730010A (en) * | 2017-01-03 | 2017-05-31 | 广州新诚生物科技有限公司 | Acellular nerve hydrogel is used to prepare the purposes of peripheral nerve injury remediation composition |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110772667A (en) * | 2019-11-15 | 2020-02-11 | 中山大学附属第一医院 | Amnion material and preparation method thereof |
| CN111281599A (en) * | 2020-03-19 | 2020-06-16 | 中国海洋大学 | A kind of reinforced artificial nerve conduit and its preparation method and application |
| CN111297513A (en) * | 2020-03-19 | 2020-06-19 | 中国海洋大学 | A kind of artificial nerve conduit loaded with trophic factor and its preparation method and application |
| CN111686306A (en) * | 2020-07-08 | 2020-09-22 | 四川大学 | 3D printing biological ink based on acellular costal cartilage matrix and preparation method and application thereof |
| CN113171494A (en) * | 2021-04-20 | 2021-07-27 | 武汉理工大学 | Method for preparing nerve-induced repair catheter by using extracellular matrix material |
| CN117085182A (en) * | 2023-08-28 | 2023-11-21 | 山东第一医科大学附属眼科研究所(山东省眼科研究所、山东第一医科大学附属青岛眼科医院) | Preparation method and application of biomimetic biological materials |
| CN117085182B (en) * | 2023-08-28 | 2024-04-09 | 山东第一医科大学附属眼科研究所(山东省眼科研究所、山东第一医科大学附属青岛眼科医院) | Preparation method and application of bionic biological material |
| WO2025044637A1 (en) * | 2023-08-28 | 2025-03-06 | 山东第一医科大学附属眼科研究所(山东省眼科研究所、山东第一医科大学附属青岛眼科医院) | Method for preparing biomimetic biomaterial and use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108939165A (en) | Peripheral nerve scaffold and preparation method thereof | |
| Osidak et al. | Collagen as bioink for bioprinting: a comprehensive review | |
| Fang et al. | Hydrogels for 3D bioprinting in tissue engineering and regenerative medicine: Current progress and challenges | |
| Naniz et al. | 4D printing: a cutting-edge platform for biomedical applications | |
| Zhang et al. | Strategies for improving the 3D printability of decellularized extracellular matrix bioink | |
| Ozbolat et al. | Application areas of 3D bioprinting | |
| CN108853583A (en) | Peripheral nerve scaffold based on 3D printing and preparation method thereof | |
| Shapira et al. | Stabilization strategies in extrusion-based 3D bioprinting for tissue engineering | |
| Lee et al. | Development of a 3D cell printed construct considering angiogenesis for liver tissue engineering | |
| Akkouch et al. | Microfabrication of scaffold-free tissue strands for three-dimensional tissue engineering | |
| Taymour et al. | Core–shell bioprinting of vascularized in vitro liver sinusoid models | |
| Wang et al. | The spatial arrangement of cells in a 3D-printed biomimetic spinal cord promotes directional differentiation and repairs the motor function after spinal cord injury | |
| CN105310794B (en) | A preparation method of a porous artificial nerve conduit with an inner wall having an orientation structure | |
| Zhu et al. | 3D printing of functional bioengineered constructs for neural regeneration: a review | |
| CN106075597B (en) | Biomimetic tissue and its preparation based on bladder acellular matrix-cell-three-dimensional fiber network | |
| US20160058911A1 (en) | Multi-step method for fabricating tissue engineering bone | |
| Rosellini et al. | Mending a broken heart by biomimetic 3D printed natural biomaterial-based cardiac patches: a review | |
| Shapira et al. | Advanced micro-and nanofabrication technologies for tissue engineering | |
| CN105944143B (en) | Based on bionical tissue of acellular matrix-cell-three-dimensional fiber network and preparation method thereof | |
| CN111467575A (en) | Myocardial cell conductive microneedle patch integrated with induced pluripotent stem cell source and preparation method and application thereof | |
| CA2874527C (en) | Collagenous foam materials | |
| Boyd-Moss et al. | Bioprinting and biofabrication with peptide and protein biomaterials | |
| Fang et al. | Clay Sculpture‐Inspired 3D Printed Microcage Module Using Bioadhesion Assembly for Specific‐Shaped Tissue Vascularization and Regeneration | |
| Mohseni et al. | Adipose tissue regeneration: Scaffold—Biomaterial strategies and translational perspectives | |
| Song et al. | Multi‐Tissue Integrated Tissue‐Engineered Trachea Regeneration Based on 3D Printed Bioelastomer Scaffolds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181207 |